Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4402160
  • Report
  • 358 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abcodia Ltd
  • BioSystems International
  • EDP Biotech Corporation
  • Lab21 Ltd
  • Onconome, Inc.
  • Scienion AG
  • MORE
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abcodia Ltd
  • BioSystems International
  • EDP Biotech Corporation
  • Lab21 Ltd
  • Onconome, Inc.
  • Scienion AG
  • MORE
1 Table of Contents
2 Introduction
2.1 Colorectal Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
4 Colorectal Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Colorectal Cancer Diagnostic Tests Companies and Product Overview
5.1 Abcodia Ltd Company Overview
5.2 Advanced Marker Discovery SL Company Overview
5.3 Advpharma Inc Company Overview
5.4 Almac Diagnostics Ltd Company Overview
5.5 Ambergen Inc Company Overview
5.6 Applied Proteomics Inc Company Overview
5.7 Arizona State University Company Overview
5.8 ArtemixRx Company Overview
5.9 Avant Diagnostics, Inc. Company Overview
5.10 Bio Mark Ltd Company Overview
5.11 Biocartis SA Company Overview
5.12 Biodesix Inc Company Overview
5.13 BioMarCare Technologies Ltd. Company Overview
5.14 BioMark Diagnostics Inc. Company Overview
5.15 BioMarker Strategies LLC Company Overview
5.16 bioMerieux S.A. Company Overview
5.17 Biomoda, Inc. (Inactive) Company Overview
5.18 Bioprognos SL Company Overview
5.19 Biosceptre International Ltd Company Overview
5.20 BioSystems International Company Overview
5.21 BioTime Inc Company Overview
5.22 Biotron Ltd Company Overview
5.23 Castle Biosciences Inc Company Overview
5.24 Catholic University of Leuven Company Overview
5.25 Cellmid Ltd Company Overview
5.26 Ceres Nanosciences Inc Company Overview
5.27 Cernostics Inc. Company Overview
5.28 China Sky One Medical Inc Company Overview
5.29 Chinese University of Hong Kong Company Overview
5.30 Chronix Biomedical Inc Company Overview
5.31 Columbia University Company Overview
5.32 Courtagen Life Sciences Inc Company Overview
5.33 CS-Keys, Inc. (Inactive) Company Overview
5.34 Di.V.A.L Toscana srl Company Overview
5.35 DiagnoCure Inc. (Inactive) Company Overview
5.36 Diaxonhit SA Company Overview
5.37 Diazyme Laboratories Inc Company Overview
5.38 DNAlytics Company Overview
5.39 EDP Biotech Corporation Company Overview
5.40 Epigenomics AG Company Overview
5.41 Eventus Diagnostics Inc (Inactive) Company Overview
5.42 Exact Sciences Corp Company Overview
5.43 Exiqon A/S Company Overview
5.44 Exosomics Siena SpA Company Overview
5.45 Fina Biotech SL Company Overview
5.46 GenomicTree Inc Company Overview
5.47 German Cancer Research Center Company Overview
5.48 Ghent University Company Overview
5.49 GlycoZym Company Overview
5.50 Health Discovery Corp Company Overview
5.51 Human Metabolome Technologies Inc Company Overview
5.52 Ikonisys Inc Company Overview
5.53 InterGenetics Inc Company Overview
5.54 IV Diagnostics, Inc. Company Overview
5.55 John Hopkins University Company Overview
5.56 King Abdullah University of Science and Technology Company Overview
5.57 Kyo Diagnostics KK Company Overview
5.58 Lab21 Ltd Company Overview
5.59 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview
5.60 Leitat Technological Center Company Overview
5.61 Lightsphere Diagnostics Company Overview
5.62 Luminor Medical Technologies Inc Company Overview
5.63 LX Diagnostics Company Overview
5.64 MabCure Inc. Company Overview
5.65 Master Diagnostica Sociedad Limitada Company Overview
5.66 Matrix-Bio, Inc. Company Overview
5.67 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview
5.68 MDNA Life Sciences Inc Company Overview
5.69 MDxHealth SA Company Overview
5.70 Merrimack Pharmaceuticals Inc Company Overview
5.71 Metabiomics Corporation Company Overview
5.72 Metabolomic Technologies Inc Company Overview
5.73 Metabolon Inc Company Overview
5.74 MetaStat Inc Company Overview
5.75 Milagen Inc Company Overview
5.76 Mode Dx Ltd. Company Overview
5.77 Myriad Genetics Inc Company Overview
5.78 Nanocytomics LLC Company Overview
5.79 Norda ASA Company Overview
5.80 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
5.81 Nuclea Biotechnologies Inc. (Inactive) Company Overview
5.82 Oncimmune (USA) LLC Company Overview
5.83 Onconome, Inc. (Inactive) Company Overview
5.84 OncoStem Diagnostics Pvt. Ltd Company Overview
5.85 OncoVista Innovative Therapies Inc Company Overview
5.86 On-Q-ity, Inc. (Inactive) Company Overview
5.87 Origin Sciences Limited Company Overview
5.88 Orion Genomics LLC Company Overview
5.89 OTraces Inc. Company Overview
5.90 Oxford Cancer Biomarkers Company Overview
5.91 Oxford Gene Technology Ltd Company Overview
5.92 PleX Diagnostics Inc (Inactive) Company Overview
5.93 Precision Biologics Inc Company Overview
5.94 Prediction Sciences LLC (Inactive) Company Overview
5.95 PreMD Inc (Inactive) Company Overview
5.96 Protagen AG Company Overview
5.97 Protein Alternatives SL Company Overview
5.98 Quest Diagnostics Inc Company Overview
5.99 Rabin Medical Center Company Overview
5.100 Rna Diagnostics Inc. Company Overview
5.101 Rosetta Genomics Ltd Company Overview
5.102 Scienion AG Company Overview
5.103 Seegene Inc Company Overview
5.104 Shuwen Biotech Co Ltd Company Overview
5.105 Siamab Therapeutics Inc Company Overview
5.106 Skuldtech France Company Overview
5.107 Sysmex Corp Company Overview
5.108 Tel Aviv University Company Overview
5.109 The Walter and Eliza Hall Institute of Medical Research Company Overview
5.110 TheraDiag SA Company Overview
5.111 Treos Bio Inc Company Overview
5.112 Trinity College Dublin Company Overview
5.113 Universal Diagnostics SL Company Overview
5.114 University of Alabama at Birmingham Company Overview
5.115 University of Illinois at Chicago Company Overview
5.116 University of Lyon Company Overview
5.117 University of Michigan Company Overview
5.118 University of Notre Dame Company Overview
5.119 University of Pittsburgh Company Overview
5.120 University of Texas MD Anderson Cancer Center Company Overview
5.121 US Biomarkers Inc Company Overview
5.122 vall d hebron institut de Recerca Company Overview
5.123 Vanderbilt University Company Overview
5.124 Viomics Inc. Company Overview
5.125 VolitionRX Ltd Company Overview
5.126 XEPTAGEN SpA Company Overview
6 Colorectal Cancer Diagnostic Tests - Recent Developments
6.1 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
6.2 Sep 05, 2017: EDP Biotech Received U.S. Patent for CA11-19 Biomarker, Methods and Compositions for Screening and Detecting Colorectal Cancer
6.3 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses
6.4 Aug 31, 2017: Strong performance data of proprietary MSI Biomarkers for the Idylla MSI Test to be published at ESMO
6.5 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
6.6 Aug 30, 2017: bioMerieux - First-Half 2017 Results
6.7 Aug 29, 2017: Todos Medical Appoints Dr. Meir Silver as Vice President of Clinical Research and Regulatory Affairs
6.8 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
6.9 Aug 17, 2017: Biohit Group Half Year Financial Report 2017
6.10 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
6.11 Aug 14, 2017: PRA Health Sciences Announces Appointment of New Director
6.12 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
6.13 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
6.14 Aug 07, 2017: PRA Health Sciences Reports Second Quarter 2017 Results and Updates Full Year 2017 Guidance
6.15 Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
6.16 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
6.17 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
6.18 Jul 31, 2017: Applied Proteomics Announces Three Additional Data Sets That Further Validate its Linus Technology, a Protein Discovery and Test Delivery Engine
6.19 Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
6.20 Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests
6.21 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9%
6.22 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review
6.23 Jul 19, 2017: Volition to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute
6.24 Jul 13, 2017: BioTime Subsidiary AgeX Therapeutics Appoints Aubrey de Grey, Ph.D. as VP of New Technology Discovery
6.25 Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017
6.26 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China
6.27 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017
6.28 Jul 03, 2017: Premaitha Health Litigation Update
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Colorectal Cancer Companies - Pipeline Products by Stage of Development
Table 7: Colorectal Cancer - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Diagnostic Assay - Colorectal Cancer - Product Status
Table 10: Diagnostic Assay - Colorectal Cancer - Product Description
Table 11: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 12: ColoFast - Product Status
Table 13: ColoFast - Product Description
Table 14: Advpharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Molecular Diagnostic Biomarker - Colorectal Cancer - Product Status
Table 16: Molecular Diagnostic Biomarker - Colorectal Cancer - Product Description
Table 17: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Status
Table 19: DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Description
Table 20: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Veracode - Colorectal Cancer - Product Status
Table 22: Veracode - Colorectal Cancer - Product Description
Table 23: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: SimpliPro Colon-A - Product Status
Table 25: SimpliPro Colon-A - Product Description
Table 26: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Biomarker Test - Colorectal Cancer - Product Status
Table 28: Biomarker Test - Colorectal Cancer - Product Description
Table 29: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
Table 30: ArtemixRx Prognostic Test - Colon Cancer - Product Status
Table 31: ArtemixRx Prognostic Test - Colon Cancer - Product Description
Table 32: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: TheraLink Assay - Colorectal Cancer - Product Status
Table 34: TheraLink Assay - Colorectal Cancer - Product Description
Table 35: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Diagnostic Test - Colorectal Adenoma - Product Status
Table 37: Diagnostic Test - Colorectal Adenoma - Product Description
Table 38: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Idylla MSI Test - Product Status
Table 40: Idylla MSI Test - Product Description
Table 41: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: VeriStrat - Colorectal Cancer - Product Status
Table 43: VeriStrat - Colorectal Cancer - Product Description
Table 44: BioMarCare Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Colon MarCarePlex - Product Status
Table 46: Colon MarCarePlex - Product Description
Table 47: mCRC-Strat - Product Status
Table 48: mCRC-Strat - Product Description
Table 49: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Metabolomics-based Diagnostic Assay - Colorectal Cancer - Product Status
Table 51: Metabolomics-based Diagnostic Assay - Colorectal Cancer - Product Description
Table 52: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Ex Vivo Biomarker Test - Colon Cancer - Product Status
Table 54: Ex Vivo Biomarker Test - Colon Cancer - Product Description
Table 55: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Diagnostic Test - Colorectal Cancer - Product Status
Table 57: Diagnostic Test - Colorectal Cancer - Product Description
Table 58: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 59: CyPath Diagnostic Assay - Colorectal Cancer - Product Status
Table 60: CyPath Diagnostic Assay - Colorectal Cancer - Product Description
Table 61: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 62: MBDAA Colorectal Cancer Test - Product Status
Table 63: MBDAA Colorectal Cancer Test - Product Description
Table 64: Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Colorectal Cancer IHC Diagnostic Test - Product Status
Table 66: Colorectal Cancer IHC Diagnostic Test - Product Description
Table 67: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Diagnostic Test - Colon Cancer - Product Status
Table 69: Diagnostic Test - Colon Cancer - Product Description
Table 70: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: PanC-Dx - Colon Cancer - Product Status
Table 72: PanC-Dx - Colon Cancer - Product Description
Table 73: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: C-Test - Colorectal Cancer - Product Status
Table 75: C-Test - Colorectal Cancer - Product Description
Table 76: Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: DecisionDx - Rectal Cancer - Product Status
Table 78: DecisionDx - Rectal Cancer - Product Description
Table 79: Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Diagnostic Test - Colorectal Cancer - Product Status
Table 81: Diagnostic Test - Colorectal Cancer - Product Description
Table 82: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 83: MK-ELISA Assay - Colorectal Cancer - Product Status
Table 84: MK-ELISA Assay - Colorectal Cancer - Product Description
Table 85: MK-ELISA Assay - Metastatic Colorectal Cancer - Product Status
Table 86: MK-ELISA Assay - Metastatic Colorectal Cancer - Product Description
Table 87: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Nanotrap Colon Cancer Biomarker Test - Product Status
Table 89: Nanotrap Colon Cancer Biomarker Test - Product Description
Table 90: Cernostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 91: TissueCypher Colon Cancer Test - Product Status
Table 92: TissueCypher Colon Cancer Test - Product Description
Table 93: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Diagnostic Kit - Rectum Cancer - Product Status
Table 95: Diagnostic Kit - Rectum Cancer - Product Description
Table 96: Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Colorectal Cancer Screening Tool - Product Status
Table 98: Colorectal Cancer Screening Tool - Product Description
Table 99: Micro-RNA Based Biomarker Assay - Colon Cancer - Product Status
Table 100: Micro-RNA Based Biomarker Assay - Colon Cancer - Product Description
Table 101: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Companion Diagnostic Test - Colorectal Cancer - Product Status
Table 103: Companion Diagnostic Test - Colorectal Cancer - Product Description
Table 104: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 105: IGFBP-3 Diagnostic Test - Product Status
Table 106: IGFBP-3 Diagnostic Test - Product Description
Table 107: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Colorectal Cancer Diagnostic Panel - Product Status
Table 109: Colorectal Cancer Diagnostic Panel - Product Description
Table 110: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 111: caPCNA - Colorectal Cancer - Product Status
Table 112: caPCNA - Colorectal Cancer - Product Description
Table 113: Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
Table 114: NanoMabKv - Colorectal Cancer - Product Status
Table 115: NanoMabKv - Colorectal Cancer - Product Description
Table 116: DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 117: Colorectal/GCC Monitoring Test - Product Status
Table 118: Colorectal/GCC Monitoring Test - Product Description
Table 119: Colorectal/Shc Prognostic Test - Product Status
Table 120: Colorectal/Shc Prognostic Test - Product Description
Table 121: Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview
Table 122: EHT Dx 12 - Product Status
Table 123: EHT Dx 12 - Product Description
Table 124: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 125: TRAIL-R2 Assay - Product Status
Table 126: TRAIL-R2 Assay - Product Description
Table 127: DNAlytics Pipeline Products & Ongoing Clinical Trials Overview
Table 128: ColonoKit - Product Status
Table 129: ColonoKit - Product Description
Table 130: DNAlytics - Ongoing Clinical Trials Overview
Table 131: ColonoKit - ColonoKit Clinical Evaluation in Colorectal Cancer Subjects
Table 132: EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 133: ColoMarker Assay - Product Status
Table 134: ColoMarker Assay - Product Description
Table 135: Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview
Table 136: Diagnostic Test - Colorectal Cancer - Product Status
Table 137: Diagnostic Test - Colorectal Cancer - Product Description
Table 138: Epi proColon 1.0 - Product Status
Table 139: Epi proColon 1.0 - Product Description
Table 140: Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Octava Test - Colon Cancer - Product Status
Table 142: Octava Test - Colon Cancer - Product Description
Table 143: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 144: PreGen-Plus - Product Status
Table 145: PreGen-Plus - Product Description
Table 146: Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 147: Colon Cancer Test - Stage III And IV Patient - Product Status
Table 148: Colon Cancer Test - Stage III And IV Patient - Product Description
Table 149: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 150: ExoTEST Colorectal - Product Status
Table 151: ExoTEST Colorectal - Product Description
Table 152: Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
Table 153: Dx Bioenergetic Signature - Colon Cancer - Product Status
Table 154: Dx Bioenergetic Signature - Colon Cancer - Product Description
Table 155: GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 156: EarlyTect Colon Cancer - Product Status
Table 157: EarlyTect Colon Cancer - Product Description
Table 158: EarlyTect Colorectal Cancer - Recurrence - Product Status
Table 159: EarlyTect Colorectal Cancer - Recurrence - Product Description
Table 160: GenomicTree Inc - Ongoing Clinical Trials Overview
Table 161: EarlyTect Colon Cancer - Clinical Study for the Validation of Real Time qPCR for SDC2 Methylation in Stool DNA for Early Detection of Colorectal Cancer
Table 162: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 163: Autoantibody Panel - Colorectal Cancer - Product Status
Table 164: Autoantibody Panel - Colorectal Cancer - Product Description
Table 165: Biomarker Panel - Colorectal Cancer - Product Status
Table 166: Biomarker Panel - Colorectal Cancer - Product Description
Table 167: Ghent University Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abcodia Ltd
  • Advanced Marker Discovery SL
  • Advpharma Inc
  • Almac Diagnostics Ltd
  • Ambergen Inc
  • Applied Proteomics Inc
  • Arizona State University
  • ArtemixRx
  • Avant Diagnostics, Inc.
  • Bio Mark Ltd
  • Biocartis SA
  • Biodesix Inc
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • bioMerieux S.A.
  • Biomoda, Inc.
  • Bioprognos SL
  • Biosceptre International Ltd
  • BioSystems International
  • BioTime Inc
  • Biotron Ltd
  • Castle Biosciences Inc
  • Catholic University of Leuven
  • Cellmid Ltd
  • Ceres Nanosciences Inc
  • Cernostics Inc.
  • China Sky One Medical Inc
  • Chinese University of Hong Kong
  • Chronix Biomedical Inc
  • Columbia University
  • Courtagen Life Sciences Inc
  • CS-Keys, Inc.
  • Di.V.A.L Toscana srl
  • DiagnoCure Inc.
  • Diaxonhit SA
  • Diazyme Laboratories Inc
  • DNAlytics
  • EDP Biotech Corporation
  • Epigenomics AG
  • Eventus Diagnostics Inc
  • Exact Sciences Corp
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fina Biotech SL
  • GenomicTree Inc
  • German Cancer Research Center
  • Ghent University
  • GlycoZym
  • Health Discovery Corp
  • Human Metabolome Technologies Inc
  • Ikonisys Inc
  • InterGenetics Inc
  • IV Diagnostics, Inc.
  • John Hopkins University
  • King Abdullah University of Science and Technology
  • Kyo Diagnostics KK
  • Lab21 Ltd
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • Leitat Technological Center
  • Lightsphere Diagnostics
  • Luminor Medical Technologies Inc
  • LX Diagnostics
  • MabCure Inc.
  • Master Diagnostica Sociedad Limitada
  • Matrix-Bio, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Merrimack Pharmaceuticals Inc
  • Metabiomics Corporation
  • Metabolomic Technologies Inc
  • Metabolon Inc
  • MetaStat Inc
  • Milagen Inc
  • Mode Dx Ltd.
  • Myriad Genetics Inc
  • Nanocytomics LLC
  • Norda ASA
  • Novel Bio-spectrum Technologies Inc
  • Nuclea Biotechnologies Inc.
  • Oncimmune (USA) LLC
  • Onconome, Inc.
  • OncoStem Diagnostics Pvt. Ltd
  • OncoVista Innovative Therapies Inc
  • On-Q-ity, Inc.
  • Origin Sciences Limited
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Cancer Biomarkers
  • Oxford Gene Technology Ltd
  • PleX Diagnostics Inc
  • Precision Biologics Inc
  • Prediction Sciences LLC
  • PreMD Inc
  • Protagen AG
  • Protein Alternatives SL
  • Quest Diagnostics Inc
  • Rabin Medical Center
  • Rna Diagnostics Inc.
  • Rosetta Genomics Ltd
  • Scienion AG
  • Seegene Inc
  • Shuwen Biotech Co Ltd
  • Siamab Therapeutics Inc
  • Skuldtech France
  • Sysmex Corp
  • Tel Aviv University
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Treos Bio Inc
  • Trinity College Dublin
  • Universal Diagnostics SL
  • University of Alabama at Birmingham
  • University of Illinois at Chicago
  • University of Lyon
  • University of Michigan
  • University of Notre Dame
  • University of Pittsburgh
  • University of Texas MD Anderson Cancer Center
  • US Biomarkers Inc
  • vall d hebron institut de Recerca
  • Vanderbilt University
  • Viomics Inc.
  • VolitionRX Ltd
  • XEPTAGEN SpA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll